Medical Tech Outlook Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook

Saliva testing is as effective as blood sampling, as experienced in the case of SARS-CoV-2 testing, but it is way more cost-effective than other testing methods.

Fremont, CA: Early intervention is essential for reducing morbidity and mortality for various diseases, including diabetes and cancer. In-vitro diagnostics that detect disease-specific biomarkers with high sensitivity are crucial for prompt diagnosis and effective treatment. While IVDs have been effective for healthcare providers, there are still significant obstacles limiting the global populace from receiving quick illness detection.

There is no one-size-fits-all answer to the problems faced by IVDs. However, the introduction of salivary diagnostic procedures – which use entire saliva and other oral sample types for biomarker detection – has led to the resolution of the last two concerns described in the preceding section. Saliva collection and testing can be a simple and inexpensive sampling technique with minimal discomfort to the end-user; it is also accurate, portable, and scalable for disease diagnosis. For a variety of diseases, including diabetes and cancer, early intervention is essential for reducing morbidity and mortality. In-vitro diagnostics (IVDs) that detect disease-specific biomarkers with sensitivity are crucial for prompt diagnosis and effective treatment. As a diagnostic tool, salivary sample types provide a number of significant advantages over conventional and historically preferred biofluids, such as blood.

Blood collection, or phlebotomy, is required for a vast array of diagnostic tests, making it one of the most common invasive medical operations. The intrusive nature of phlebotomy might expose healthcare practitioners to blood-borne diseases, such as HIV, hepatitis viruses, germs, and parasites, even though it is generally considered a vital aspect of diagnostic procedures.

The usage of needles creates many difficulties for patients. Patients who are uncomfortable with the use of needles or the sight of blood may experience a range of vasovagal reactions. Patients typically endure pain and bruises. Finally, inadequate sterilizing prior to venipuncture might result in the direct entry of microorganisms into the bloodstream.

Since the COVID-19 pandemic began, nasopharyngeal swabbing has been the "go-to" sampling method for viral testing. However, a key advantage of saliva collection and testing is that it is a non-invasive collection procedure. This characteristic alone attracts the attention of both healthcare providers and patients. As saliva diagnostics have begun to be utilized for SARS-CoV-2 testing, its advantages over nasopharyngeal swabbing have become evident. The latter leads patients to sneeze and cough, which raises the chance of viral transmission and causes mild to severe discomfort.

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

However, if you would like to share the information in this article, you may use the link below:

www.medicaltechoutlook.com/news/saliva-testing-becoming-a-significant-part-of-in-vitro-diagnostics-nwid-2258.html